gIcare pharma Inc. is developing a pipeline of non-sedating colonic analgesic compounds to provide new and lower cost alternatives for pain management during colonoscopy.

Sedation during endoscopy has become routine practice among gastroenterologists, even though Medicare and insurance carriers do not always reimburse for the drug or anesthesiologist services, except in high risk cases.